Name
ImmunoGen, Inc.
Company Description
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOWâ„¢. ImmunoGen is now part of AbbVie. Learn more about who we are, what we do, and how we do it at abbvie.com/oncology or elahere.com.
Featured Exhibitor
Yes
Product Categories (7)
Gynecologic Cancer, Hematologic Cancers, Biomarkers, Clinical Trials, Pharmaceutical
Conquer Cancer Council Member
Yes
Phone (If provided, phone will display online and in-print)
781-895-0600
Address
Waltham, MA
United States

Recognition

Conquer Cancer Council Member
Featured Exhibitor

Products

Relevance
ImmunoGen